igeneTRACK™ Cancer Test

cfNA Saliva Detection Technology

Quantitative tracking of cancer cell number trends at carcinoma sites

Suitable Candidates for Testing

Cancer patients 

Technical Advantages

Patients diagnosed with cancer are tested for specific mRNA expression and specific gene sequence mutations prior to treatment and the individual standard values ​​are quantified. Following treatment, regular screening (every 3 months) will determine the following:

  • Cancer cell number trends in the body

  • Whether or not cancer cells have developed a drug resistance

  • Metastasis or recurrence

  • Guidelines for selecting treatment methods

At the same time, the number of circulating tumor cells in the body can be determined.

  • Facebook - Geneaid
  • Twitter - Geneaid
  • YouTube - Geneaid
  • Instagram - Geneaid

©2019 by Geneaid Biomed All Rights Reserved

Geneaid Logo_white.png